Friday 6 November 2026
Export CL’s income statement to Excel — free account
Colgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Revenue
- +4.64%
- EPS
- +7.42%
- Free cash flow
- −6.24%
- Total debt
- −8.35%
Quarter to September 2026, against a year earlier
96.89
1.80
−1.82%
Follow CL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
30.05 | 32.91 | 36.09 | 32.72 |
P/S ratio |
3.14 | 3.29 | 3.48 | 3.19 | |
P/FCF ratio |
17.58 | 18.15 | 19.00 | 17.94 | |
P/Operating CF |
43.98 | 91.54 | 73.66 | 58.06 | |
P/B ratio |
175.08 | 140.70 | 129.49 | 106.24 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.46 | 3.61 | 3.79 | 3.49 | |
EV/EBITDA |
14.54 | 15.79 | 17.01 | 15.71 | |
EV/Operating CF |
16.82 | 17.27 | 17.90 | 16.99 | |
EV/FCF |
19.43 | 19.91 | 20.68 | 19.58 | |
Quick Ratio |
0.43 | 0.54 | 0.54 | 0.52 | |
Current Ratio |
0.83 | 1.02 | 1.03 | 0.96 | |
Net Debt/EBITDA |
5.66 | 5.93 | 5.54 | 4.96 | |
Debt/Assets |
48.92% | 48.00% | 46.80% | 46.09% | |
Debt/Equity |
21.88 | 16.41 | 13.88 | 12.06 | |
Asset Turnover |
1.26 | 1.25 | 1.23 | 1.24 | |
Operating CF/Net income |
(40.36) | 1.16 | 1.44 | 1.56 | |
Capex/Depreciation |
(0.16) | (0.88) | (0.83) | (0.84) | |
Interest Coverage |
1.44 | 15.55 | 16.39 | 17.55 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.60% | 38.99% | 39.73% | 39.32% | |
Intangible Assets out of Total Assets |
0.29 | 0.28 | 0.27 | 0.27 | |
Share Based Compensation of Revenue |
0.54% | 0.75% | 0.71% | 1.17% | |
Graham Net Nets |
(0.16) | (0.15) | (0.14) | (0.14) | |
Graham Number |
5.17 | 5.94 | 6.36 | 6.86 | |
Earnings Yield |
3.33% | 3.04% | 2.77% | 3.06% | |
Free Cash Flow Yield |
5.69% | 5.51% | 5.26% | 5.57% | |
Revenue per Share |
6.47 | 6.64 | 6.71 | 6.74 | |
Operating CF per Share |
1.80 | 0.93 | 1.24 | 1.47 | |
Capex per Share |
(0.22) | (0.17) | (0.16) | (0.17) | |
Free Cash Flow per Share |
1.58 | 0.76 | 1.08 | 1.30 | |
Cash per Share |
1.59 | 1.66 | 1.71 | 1.92 | |
Shareholders Equity per Share |
0.45 | 0.61 | 0.71 | 0.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.45 | 0.61 | 0.71 | 0.80 | |
Free Cash Flow |
1,276.00 | 609.00 | 867.00 | 1,037.00 | |
Working Capital |
(1,144.00) | 148.00 | 160.00 | (282.00) | |
Capital Expenditures |
(177.00) | (138.00) | (128.00) | (134.00) | |
Net Current Asset Value |
(10,256.00) | (10,042.00) | (9,916.00) | (9,745.00) | |
EV/EBIT |
21.36 | 23.49 | 25.49 | 23.48 | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.03 | |
Price to Operating Income |
19.33 | 21.41 | 23.42 | 21.52 | |
| Other line items | |||||
Average Receivables |
1,598.00 | 1,807.00 | 1,867.50 | 1,854.00 | |
Average Payables |
1,947.00 | 1,948.00 | 1,952.50 | 1,981.00 | |
Average Inventory |
2,009.50 | 2,105.50 | 2,150.50 | 2,145.50 | |
Average Assets |
16,188.00 | 16,628.50 | 17,130.00 | 17,127.50 | |
Average Common Equity |
454.50 | 609.50 | 809.00 | 939.00 |
Columns are period end dates · fundamentals updated 3 Nov 2026